| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.009 |